Bridgeway Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-51,500
| Closed | -$111K | – | 1311 |
|
|
2024
Q3 | $111K | Hold |
51,500
| – | – | ﹤0.01% | 1152 |
|
|
2024
Q2 | $266K | Hold |
51,500
| – | – | 0.01% | 992 |
|
|
2024
Q1 | $276K | Buy |
51,500
+12,000
| +30% | +$64.2K | 0.01% | 1054 |
|
|
2023
Q4 | $308K | Hold |
39,500
| – | – | 0.01% | 1059 |
|
|
2023
Q3 | $156K | Hold |
39,500
| – | – | ﹤0.01% | 1141 |
|
|
2023
Q2 | $124K | Sell |
39,500
-10,000
| -20% | -$31.5K | ﹤0.01% | 1223 |
|
|
2023
Q1 | $132K | Buy |
+49,500
| New | +$132K | ﹤0.01% | 1181 |
|
|
2022
Q3 | – | Sell |
-9,500
| Closed | -$91K | – | 1460 |
|
|
2022
Q2 | $91K | Sell |
9,500
-7,500
| -44% | -$71.8K | ﹤0.01% | 1238 |
|
|
2022
Q1 | $202K | Hold |
17,000
| – | – | ﹤0.01% | 1170 |
|
|
2021
Q4 | $554K | Buy |
+17,000
| New | +$554K | 0.01% | 953 |
|
|
2020
Q1 | – | Sell |
-3,330
| Closed | -$230K | – | 1368 |
|
|
2019
Q4 | $230K | Hold |
3,330
| – | – | ﹤0.01% | 1177 |
|
|
2019
Q3 | $346K | Hold |
3,330
| – | – | ﹤0.01% | 1063 |
|
|
2019
Q2 | $308K | Sell |
3,330
-4,000
| -55% | -$370K | ﹤0.01% | 1090 |
|
|
2019
Q1 | $670K | Buy |
7,330
+740
| +11% | +$67.6K | 0.01% | 911 |
|
|
2018
Q4 | $367K | Sell |
6,590
-2,000
| -23% | -$111K | ﹤0.01% | 1086 |
|
|
2018
Q3 | $1.02M | Hold |
8,590
| – | – | 0.01% | 870 |
|
|
2018
Q2 | $877K | Sell |
8,590
-1,380
| -14% | -$141K | 0.01% | 924 |
|
|
2018
Q1 | $1.29M | Buy |
+9,970
| New | +$1.29M | 0.01% | 747 |
|